Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,951,219 papers from all fields of science
Search
Sign In
Create Free Account
HB 7
Known as:
HB-7
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Teoría de Dorothea Orem- proceso atención de enfermería aplicado al autocuidado del adulto mayor diabético en el HB-7 Loja
Quinaucho Gutiérrez
,
Dolores Gabriela
2019
Corpus ID: 199619629
Self-care is an activity which people do in order to performs their own benefit and maintain their life, it refers to self…
Expand
1997
1997
Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines.
S. Inoue
,
K. Kontani
,
+5 authors
T. Katada
Journal of Immunology
1997
Corpus ID: 24173629
The human surface Ag CD38 is a 46-kDa type II transmembrane glycoprotein, and its expression is dependent on the cell…
Expand
1997
1997
Potentiation of chemotactic peptide-induced superoxide generation by CD38 ligation in human myeloid cell lines.
N. Tsujimoto
,
K. Kontani
,
+4 authors
T. Katada
Journal of Biochemistry (Tokyo)
1997
Corpus ID: 25106465
CD38 is a type II transmembrane glycoprotein possessing an NAD+ glycohydrolase activity in its extracellular domain. We…
Expand
1990
1990
Anticonvulsive activity of a barbiturate derivative HB-7 in a model of allylglycine-induced epilepsy in cats.
D. Getova
,
S. Moyanova
,
V. Georgiev
,
V. Ivanova
Acta physiologica et pharmacologica Bulgarica
1990
Corpus ID: 21201453
With the aim of characterizing further the anticonvulsive activity of the newly-synthesized barbituric derivative 2-hydroxylamino…
Expand
1990
1990
[The effect of the newly synthesized barbiturate HB-7, phenobarbital and pentobarbital on the GABA content of the brain in rats].
D. Getova
Eksperimentalna meditsina i morfologiia
1990
Corpus ID: 24187539
The content of GABA in the following regions of the brain: cerebellum, left and right hemisphere was studied on white male rats…
Expand
1990
1990
Investigation of 2-hydroxylamino-5-ethyl-5-sec-pentylbarbituric acid for anxyolitic action.
D. Getova
,
V. Georgiev
,
V. Ivanova
Acta physiologica et pharmacologica Bulgarica
1990
Corpus ID: 34188076
Comparative tests were performed on male albino rats to study the activity of the original hydroxylamine barbiturate HB-7, with…
Expand
1989
1989
Antihypoxic effect of the hydroxylamine derivative HB-7.
D. Getova
,
V. Georgiev
Acta physiologica et pharmacologica Bulgarica
1989
Corpus ID: 33140504
The antihypoxic effect of the newly-synthesized hydroxylamine barbiturate HB-7, compared with the effects of phenobarbital and…
Expand
1988
1988
Anticonvulsive effect of 2-hydroxylamine-5-ethyl-5-sec-pentyl barbituric acid (HB-7) in two experimental models of epilepsy.
D. Getova
,
S. Moyanova
Methods and Findings in Experimental and Clinical…
1988
Corpus ID: 20925261
The effects of barbiturate HB-7 (2-hydroxylamine-5-ethyl-5-sec-pentylbarbituric acid) injected intraperitoneally compared to the…
Expand
1988
1988
GABA-ergic mechanisms in the anticonvulsive activity of newly synthesized barbiturates. II. Correlation of HB-7 with GABA-ergic agents.
D. Getova
,
V. Georgiev
Acta physiologica et pharmacologica Bulgarica
1988
Corpus ID: 23383192
The effect of the newly synthesized barbiturate HB-7 (2-hydroxylamino-5-ethyl-5-sec. pentylbarbituric acid) was investigated in…
Expand
1988
1988
Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
D. Getova
,
V. Markovska
Acta physiologica et pharmacologica Bulgarica
1988
Corpus ID: 23529926
The effects of two newly synthesized barbiturates--HB-7 (2-hydroxylamino-5-ethyl-5-sec. pentylbarbituric acid) and HB-2 (2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE